CD4 News and Research

RSS
Researchers uncover how HIV causes abnormalities in antibody-producing cells

Researchers uncover how HIV causes abnormalities in antibody-producing cells

Generic tritherapy can be used as a basic treatment for AIDS

Generic tritherapy can be used as a basic treatment for AIDS

Counseling for breast cancer patients means healthier diets, reduced smoking and stronger immune systems

Counseling for breast cancer patients means healthier diets, reduced smoking and stronger immune systems

Highly active antiretroviral therapies for AIDS are not initiated soon enough

Highly active antiretroviral therapies for AIDS are not initiated soon enough

Major trends in AIDS research that the different research teams throughout the world are pursuing

Major trends in AIDS research that the different research teams throughout the world are pursuing

Solid evidence that best treatment for multiple sclerosis is pregnancy

Solid evidence that best treatment for multiple sclerosis is pregnancy

FDA reinforces use of Sustiva in first-line HIV combination therapy

FDA reinforces use of Sustiva in first-line HIV combination therapy

Genmab's HuMax-CD4 receives U.S. orphan drug designation

Genmab's HuMax-CD4 receives U.S. orphan drug designation

South Africa will continue providing Nevirapine as monotherapy to mothers and babies

South Africa will continue providing Nevirapine as monotherapy to mothers and babies

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

A new vaccine that may delay cancer recurrence

A new vaccine that may delay cancer recurrence

International pharmaceutical industries and governments are failing to develop and produce AIDS medicines

International pharmaceutical industries and governments are failing to develop and produce AIDS medicines

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

Immunotherapeutic strategy allowing patients to use their own immune system to fight their cancer

Immunotherapeutic strategy allowing patients to use their own immune system to fight their cancer

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

A new protocol for bone marrow transplants

A new protocol for bone marrow transplants

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

Women delay AIDS with vitamins B, C and E

Women delay AIDS with vitamins B, C and E